Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

220
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
220

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Finerenone and Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial.

JAMA cardiology·2026
Same author

Health Status in Heart Failure With Preserved Ejection Fraction in Asia: Insights From Global Trials.

JACC. Asia·2026
Same author

Effect of Recruitment Video Presenter Sex on Trial Enrollment.

JAMA·2026
Same author

Sleep Apnea in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial.

JACC. Heart failure·2026
Same author

Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial.

European journal of preventive cardiology·2026
Same author

Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART Analysis.

Journal of the American College of Cardiology·2026
Same journal

Lactate Metabolism Dysregulation Drives the Pathogenesis of Acute Kidney Injury.

Metabolites·2026
Same journal

Librarian: An Open-Access Web Application for High-Resolution Mass Spectral Library Assembly.

Metabolites·2026
Same journal

Purine Metabolism Alterations in Patients with Chronic Heart Failure: A Cross-Sectional Study of Associations with Iron Status, Oxidative Stress, and Anemia.

Metabolites·2026
Same journal

The Gut Microbiome in Heart Failure: Pathways to Inflammation and Therapeutic Targets.

Metabolites·2026
Same journal

Metabolic Mechanisms of Hexavalent Chromium-Induced Splenic Immune Injury via Oxidative Stress and Ferroptosis Pathways in New Zealand Rabbits.

Metabolites·2026
Same journal

Improving Speed and Efficiency of DESI Imaging with the Xevo MRT Mass Spectrometer for Analyte Mapping.

Metabolites·2026
See all related articles

Related Experiment Video

Updated: Sep 7, 2025

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.1K

Quantitative Comparison of Statistical Methods for Analyzing Human Metabolomics Data.

Mir Henglin1,2, Brian L Claggett1, Joseph Antonelli1,3,4

  • 1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Metabolites
|June 23, 2022
PubMed
Summary
This summary is machine-generated.

Statistical learning methods for human metabolomics data are compared. Sparse multivariate models are recommended for analyzing high-dimensional metabolomics data, especially in nontargeted studies, to improve biological insights and statistical power.

Keywords:
metabolomicsmultivariatestatistical methodsunivariate

More Related Videos

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

641
A New Approach for the Comparative Analysis of Multiprotein Complexes Based on 15N Metabolic Labeling and Quantitative Mass Spectrometry
08:04

A New Approach for the Comparative Analysis of Multiprotein Complexes Based on 15N Metabolic Labeling and Quantitative Mass Spectrometry

Published on: March 13, 2014

12.3K

Related Experiment Videos

Last Updated: Sep 7, 2025

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.1K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

641
A New Approach for the Comparative Analysis of Multiprotein Complexes Based on 15N Metabolic Labeling and Quantitative Mass Spectrometry
08:04

A New Approach for the Comparative Analysis of Multiprotein Complexes Based on 15N Metabolic Labeling and Quantitative Mass Spectrometry

Published on: March 13, 2014

12.3K

Area of Science:

  • Biostatistics
  • Computational Biology
  • Human Metabolomics

Background:

  • Emerging mass spectrometry technologies enable large-scale metabolomics profiling of biosamples.
  • Standardized statistical methods for analyzing high-dimensional human metabolomics data in relation to clinical phenotypes are lacking.
  • Understanding disease pathogenesis requires robust analysis of complex metabolomics datasets.

Purpose of the Study:

  • To formally compare traditional and newer statistical learning methods for analyzing human metabolomics data.
  • To determine optimal statistical approaches for high-dimensional metabolomics datasets across various scenarios.
  • To evaluate methods based on dataset characteristics, including sample size and number of metabolites.

Main Methods:

  • Comparison of univariate and multivariate statistical learning methods.
  • Analysis of simulated and experimental metabolomics data from large human cohorts.
  • Evaluation across different dataset types, including nontargeted and targeted metabolomics.

Main Results:

  • Univariate methods showed a higher apparent false discovery rate with increasing study subjects.
  • Multivariate methods performed favorably, especially with a higher number of assayed metabolites (nontargeted metabolomics).
  • Sparse multivariate models demonstrated superior selectivity, reduced spurious relationships, and robust statistical power in nontargeted metabolomics, particularly when metabolites outnumbered subjects.

Conclusions:

  • Sparse multivariate models are recommended for analyzing nontargeted metabolomics data in human disease studies.
  • These methods offer improved selectivity and statistical power, reducing biologically less informative associations.
  • Findings have significant implications for advancing metabolomics analysis in human disease research.